Dihydronicotinamide Riboside Is a Potent NAD+ Precursor Promoting a Pro-Inflammatory Phenotype in Macrophages

Abstract

Nicotinamide adenine dinucleotide (NAD) metabolism plays an important role in the regulation of immune function. However, a complete picture of how NAD, its metabolites, precursors, and metabolizing enzymes work together in regulating immune function and inflammatory diseases is still not fully understood. Surprisingly, few studies have compared the effect of different forms of vitamin B3 on cellular functions. Therefore, we investigated the role of NAD boosting in the regulation of macrophage activation and function using different NAD precursors supplementation. We compared nicotinamide mononucleotide (NMN), nicotinamide riboside (NR), and nicotinamide (NAM) supplementation, with the recently described potent NAD precursor NRH. Our results show that only NRH supplementation strongly increased NAD+ levels in both bone marrow-derived and THP-1 macrophages. Importantly, NRH supplementation activated a pro-inflammatory phenotype in resting macrophages, inducing gene expression of several cytokines, chemokines, and enzymes. NRH also potentiated the effect of lipopolysaccharide (LPS) on macrophage activation and cytokine gene expression, suggesting that potent NAD+ precursors can promote inflammation in macrophages. The effect of NRH in NAD+ boosting and gene expression was blocked by inhibitors of adenosine kinase, equilibrative nucleoside transporters (ENT), and IκB kinase (IKK). Interestingly, the IKK inhibitor, BMS-345541, blocked the mRNA expression of several enzymes and transporters involved in the NAD boosting effect of NRH, indicating that IKK is also a regulator of NAD metabolism. In conclusion, NAD precursors such as NRH may be important tools to understand the role of NAD and NADH metabolism in the inflammatory process of other immune cells, and to reprogram immune cells to a pro-inflammatory phenotype, such as the M2 to M1 switch in macrophage reprogramming, in the cancer microenvironment.

An Axis between the Long Non-Coding RNA HOXA11-AS and NQOs Enhances Metastatic Ability in Oral Squamous Cell Carcinoma

“…NQO2 differs from NQO1 in that it requires NRH as a coenzyme [10]. NRH is a precursor of NAD [37] and increases intracellular NAD levels [38,39]. Our experiments showed that an increase in NQO2 following HOXA11-AS knockdown resulted in a decrease in NAD concentration.…”

The identification of new roles for nicotinamide mononucleotide after spinal cord injury in mice: an RNA-seq and global gene expression study

“…NMN can also improve STRT1 function and cause alterations in macrophage phagocytosis and M1 polarization via the SIRT1, IL-17A, and Notch pathways ( Meng et al, 2021 ). Other studies have shown that NMN exerts neuroprotective effects by inhibiting neuronal apoptosis and death, delaying neuroinflammation, affecting macrophage polarization, and protecting the integrity of the blood-brain barrier ( Kitaoka et al, 2009 ; Wei et al, 2017a , b ; Harlan et al, 2019 ; Chen et al, 2020 ; Chini et al, 2022 ). SIRT2 is essential for LPS-induced microglial cell activation, and inhibiting SIRT2 can reduce microglial cell activation, alleviate neuroinflammation, decrease dopamine neuronal death, and delay Parkinson’s disease neuroinflammation.…”

Supplementation with NAD+ and its precursors: A rescue of female reproductive diseases

“…NMNH is the reduced form of NMN, which is converted to NAD + by NMNAT and inhibits glycolysis, the TCA cycle, and cell growth [ 29 ]. Surprisingly, NRH and NMNH increased NAD + levels to a much greater extent than NR and NMN [ 29 , 30 ].…”